![Neuro-Oncology: The Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/cc/28/2a/cc282a22-e82c-cb69-915e-e1f1bc535ff2/mza_14070868688336688079.jpg/100x100bb.jpg)
Intrathecal trastuzumab for leptomeningeal metastases
Neuro-Oncology: The Podcast
English - August 11, 2023 14:08 - 21 minutes - 19.3 MB - ★★★★★ - 9 ratingsMedicine Health & Fitness Science Life Sciences brain oncology tumors glioblastoma glioma lymphoma neurology neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Short term topiramate for radiation induced cytotoxic edema
Next Episode: Dendritic cell vaccines in gliomas
Dr. Iyad Alnahhas interviews Drs. Priya Kumthekar and Jeffrey Raizer about their recent manuscript entitled: A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2- positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics", published online in Neuro-Oncology in March 2023.